The Global Asthma Report 2022
Home
Summaries
Foreword
Preface
Executive Summary
Key Recommendations
The Burden of Asthma
Global Asthma Network
Asthma and Factors Affecting it
The Global Burden of Asthma
Asthma Deaths
Global Asthma Management and Asthma Control
COVID-19 and Asthma
Asthma in the WHO Regions
Asthma in the African Region
Asthma in the Region of the Americas
Asthma in the Eastern Mediterranean Region
Asthma in the European Region
Asthma in the South-East Asian Region
Asthma in the Western Pacific Region
Improving Asthma Management
New Approaches with Asthma Medicines
Asthma in the Context of other Chronic Respiratory Diseases in LMICs
Improving Access to Essential Asthma Medicines
Asthma Management in Low- and Middle-Income Countries
The role of patient advocacy
Asthma, Climate Change and Planetary Health
Maps, Data, Resources
Maps, Data, and Resources
Glossary
References
Authors
GAN Phase I Study Group
Acknowledgements
☰
Glossary
AAIP
Allergy and Asthma Institute Pakistan
ADF
Asthma Drug Facility
BiPAP
Bilevel positive airways pressure
CME
Continued medical education
CMSs
Central medical stores
COPD
Chronic obstructive pulmonary disease
COVID-19
Coronavirus disease 2019
CPAP
Continuous positive airways pressure
CRD
Chronic respiratory diseases
DALYs
Disability adjusted life years
DOTS
Directly observed treatment, short-course
ED
Emergency Department
EML
Essential Medicines List
EMRO
Eastern Mediterranean Region
FIRS
Forum of International Respiratory Societies
GAAPP
Global Allergy and Airways Patient Platform
GAN
Global Asthma Network
GAR
Global Asthma Report
GARD
Global Alliance against Chronic Respiratory Diseases
GBD
Global Burden of Disease
GEMA
Guía Española para el Manejo del Asma
GINA
Global Initiative for Asthma
GOLD
Global Initiative for Obstructive Lung Diseases
HCC
Healthy Caribbean Coalition
HDI
Human Development Index
ICS
Inhaled corticosteroids
ICS+LABA
Combinations of ICS and LABA
IMSS
Instituto Méxicano de Seguro Social
INSABI
National Instituto de Salud para el Bienestar
ISAA
Iranian Society of Asthma and Allergy
ISAAC
International Study of Asthma and Allergies in Childhood
ISSSTE
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
KSA
Kingdom of Saudi Arabia
LABA
Long-acting β2-agonist
LMICs
Low- and middle-income countries
LTRA
Leukotriene receptor antagonists
MDI
Metered dose inhaler
MHE
Ministry of Higher Education
MIA
Manejo Integral del Asma
MOH
Ministry of Health
NACP
National Asthma Control Program
NCD
Non-communicable disease
NGOs
Non-governmental organisations
NO2
Nitrogen dioxide
NRAD
National Review of Asthma Deaths
NZ
New Zealand
OCS
Oral corticosteroids
OR
Odds ratios
oSABA
Oral SABA
PACK
Package of Care Kit
PAL
Practical Approach to Lung Disease
PATS
Pan African Thoracic Society
PEN
Package of essential non-communicable disease Interventions for primary health care
PHCs
Public Health Centres
PIPA
Children’s Asthma Prevention Program
PM2.5
Particulate matter 2.5 microns
PTLD
Post-tuberculosis lung disease
r
Rank correlation
RBM
Roll Back Malaria
SABA
Short-acting β2-agonists
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
SDG
Sustainable Development Goals
SINA
Saudi Initiative for Asthma
TB
Tuberculosis
The Union
International Union against Tuberculosis and Lung Disease
TRAP
Traffic related air pollution
WAO
World Allergy Organization
WHO
World Health Organization
YLD
Years lived with disability
YLL
Years of life lost
Next: References >
Maps, Data, and Resources
Glossary
References
Authors
GAN Phase I Study Group
Acknowledgements
Download the 2022 Report
2018 Report
2014 Report
2011 Report
Global Asthma Network
The global epidemic of NCDs is a major and growing challenge to development.
Next: References >